Altos Biologics Overview
- Year Founded
-
2020
- Status
-
Acquired/Merged
- Employees
-
16
- Latest Deal Type
-
2ndary - Private
- (Announced)
Altos Biologics General Information
Description
Developer of human hyaluronidase technology designed to facilitate global technology transfer. The company's technology helps in the treatment of various complex health issues, enabling doctors to cure patients' diseases.
Contact Information
Website
www.altosbiologics.comCorporate Office
- 8th floor, 15, Teheran-ro 84-gil
- Daechi-dong, Simon Tower, Gangnam-gu
- Seoul, 06179
- South Korea
Corporate Office
- 8th floor, 15, Teheran-ro 84-gil
- Daechi-dong, Simon Tower, Gangnam-gu
- Seoul, 06179
- South Korea
Altos Biologics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | 06-Oct-2026 | Announced | Generating Revenue | |||
| 3. Merger/Acquisition | 22-May-2025 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 09-Jul-2024 | $17.7M | $164M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 14-Jan-2021 | $146M | $146M | Completed | Generating Revenue |
Altos Biologics Signals
Altos Biologics Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| DS Asset Management | Asset Manager | Minority | ||
| G.N. Tech Venture Capital | Venture Capital | Minority | ||
| Hanlim Pharm | Corporation | Minority | ||
| Industrial Bank of Korea | PE/Buyout | Minority | ||
| Magna Investment (Seoul) | Venture Capital | Minority |
Altos Biologics FAQs
-
When was Altos Biologics founded?
Altos Biologics was founded in 2020.
-
Where is Altos Biologics headquartered?
Altos Biologics is headquartered in Seoul, South Korea.
-
What is the size of Altos Biologics?
Altos Biologics has 16 total employees.
-
What industry is Altos Biologics in?
Altos Biologics’s primary industry is Biotechnology.
-
Is Altos Biologics a private or public company?
Altos Biologics is a Private company.
-
What is Altos Biologics’s current revenue?
The current revenue for Altos Biologics is .
-
How much funding has Altos Biologics raised over time?
Altos Biologics has raised $164M.
-
Who are Altos Biologics’s investors?
DS Asset Management, G.N. Tech Venture Capital, Hanlim Pharm, Industrial Bank of Korea, and Magna Investment (Seoul) are 5 of 8 investors who have invested in Altos Biologics.
-
When was Altos Biologics acquired?
Altos Biologics was acquired on 06-Oct-2026.
-
Who acquired Altos Biologics?
Altos Biologics was acquired by Alteogen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process